Acute Study to Investigate the Interaction of Cocoa Methylxanthines With Cocoa Flavanol Related Vascular Effects
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cardiovascular Diseases
- Sponsor
- Heinrich-Heine University, Duesseldorf
- Enrollment
- 36
- Locations
- 1
- Primary Endpoint
- Endothelial function
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
Epidemiological studies suggest that certain foods rich in flavanols, including cocoa products, red wine, and tea, are associated with decreased cardiovascular mortality and morbidity. Dietary interventional studies have corroborated this finding and showed that flavanols can acutely and after sustained ingestion improve surrogate markers of cardiovascular risk including endothelial function. Endothelial dysfunction is the key event in the development and progression of cardiovascular disease. Aging is the major non-modifiable cardiovascular risk factor associated with progressive decline in endothelial function, vascular stiffening and increase in blood pressure.
However, in addition to flavanols, other potentially bioactive compounds are present in cocoa, in particular methylxanthines. Little is known about the vascular effects of cocoa methylxanthines, i.e. mainly theobromine, in particular when consumed together with flavanols in cocoa products. The aim of the study is to characterize the nutrient-nutrient interaction between cocoa flavanols and cocoa methylxanthines.
Investigators
Klinik für Kardiologie, Pneumologie und Angiologie
Klinik für Kardiologie, Pneumologie und Angiologie
Heinrich-Heine University, Duesseldorf
Eligibility Criteria
Inclusion Criteria
- •healthy male subjects
- •\>18 years
Exclusion Criteria
- •acute inflammation
- •cardiac arrhythmia
- •renal failure
- •heart failure (NYHA II-IV)
- •diabetes mellitus
- •CRP \> 1 mg/dl
- •malignant disease
Outcomes
Primary Outcomes
Endothelial function
Time Frame: 2 hours
Flow mediated dilatation (FMD)
Plasma flavanol metabolites
Time Frame: 2 hours
Measured by HPLC
Secondary Outcomes
- Ambulatory blood pressure(2 hours)
- Circulation angiogenetic cells(2 hours)
- Pulse wave velocity(2 hours)